What's new

Highlights - Second EMA / Alliance for Regenerative Medicine bilateral meeting

Highlights - Second EMA / Alliance for Regenerative Medicine bilateral meeting

Jun 5, 2025 - 15:00
 0
Highlights - Second EMA / Alliance for Regenerative Medicine bilateral meeting
Read More

Tags:

Previous Article

STAT+: Pharmalittle: We’re reading about Novo Nordisk’s cautious culture, FDA ap...

Next Article

Orphan designation: defibrotide Prevention of hepatic veno-occlusive disease, 29...

Related Posts

Human medicines European public assessment report (EPAR): Veklury, remdesivir, Date of authorisation: 03/07/2020, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 4, 2025  0

Human medicines European public assessment report (EPAR): Kostaive, zapomeran, Date of authorisation: 12/02/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0

Human medicines European public assessment report (EPAR): Eksunbi, ustekinumab, Date of authorisation: 12/09/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

May 26, 2025  0